Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone Lymphoma, Clinical Guidelines

Andrew Zelenetz

MD, PhD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Vice Chair, Department of Medicine

66
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Andrew Zelenetz is chair of the NCCN Non-Hodgkin's Lymphoma Guidelines Committee and has significantly shaped clinical practice recommendations for marginal zone lymphoma and other indolent B-cell malignancies. His research encompasses treatment algorithms, biomarker-directed therapy, and emerging agents for B-cell lymphomas. He is widely recognized as one of the definitive voices in lymphoma guideline development.

Share:

🧪Research Fields 研究领域

lymphoma clinical guidelines
NCCN lymphoma
MZL treatment algorithm
follicular lymphoma
anti-CD20 therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Andrew Zelenetz 的研究动态

Follow Andrew Zelenetz's research updates

留下邮箱,当我们发布与 Andrew Zelenetz(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment